BEVERLY, Mass. and TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced the appointment, of Dr.

马萨诸塞州贝弗利和多伦多，2023年12月21日（环球通讯社）--汉密尔顿·索恩有限公司（TSX:HTL）是辅助生殖技术（ART），研究和细胞生物学市场的精密仪器，耗材，软件和服务的领先提供商，今天宣布任命博士。

Ekaterina (Kate) Torchilin as its new President and Chief Executive Officer, effective January 15, 2024. Dr. Torchilin is succeeding David Wolf, who is retiring as President and CEO. Mr. Wolf will continue to serve the Company as Executive Chairman. Dr. Torchilin will also join the Hamilton Thorne Board of Directors upon assuming the CEO role.

叶卡捷琳娜（KateTorchilin）出任新总裁兼首席执行官，自2024年1月15日起生效。托奇林博士接替即将退休的总裁兼首席执行官大卫·沃尔夫。沃尔夫先生将继续担任公司执行董事长。托奇林博士在担任首席执行官后也将加入汉密尔顿·索恩董事会。

Dr. Torchilin is currently the President of the Biologicals and Chemicals Division at Thermo Fisher Scientific, where is she is responsible for the development, manufacture, and global commercialization of the cell culture, cell therapy and chemical business that supports the manufacturing of vaccines and biologics therapies.

Torchilin博士目前是Thermo Fisher Scientific生物制品和化学品部门的总裁，负责支持疫苗和生物制剂生产的细胞培养、细胞治疗和化学业务的开发、制造和全球商业化。

Dr. Torchilin began her career at Thermo Fisher supporting strategic mergers and acquisitions in their Life Sciences Group, and has successfully progressed through a series of operational and general management roles at continually larger businesses, including serving as Vice President and General Manager of their Purification and Pharma Analytics business and Vice President and General Manager of their Cell Culture and Cell Therapy business.

Torchilin博士的职业生涯始于Thermo Fisher，为其生命科学集团的战略并购提供支持，并在不断扩大的企业中成功地担任了一系列运营和一般管理角色，包括担任纯化和药物分析业务的副总裁和总经理，以及细胞培养和细胞治疗业务的副总裁和总经理。

Dr. Torchilin also has over 20 years of experience in the life sciences and healthcare industries, including, serving as Global Head of Connected Health and Women's Health at Alere, Inc., where she was responsible for their global business in diagnostic testing supporting healthy pregnancy. Dr. Torchilin earned a PhD.

Torchilin博士在生命科学和医疗保健行业也有20多年的经验，包括在Alere，Inc.担任互联健康和妇女健康全球负责人，负责支持健康怀孕的诊断测试全球业务。托奇林博士获得了博士学位。

in biochemistry from Tufts University and an MBA from Har.

塔夫茨大学生物化学专业，哈佛大学工商管理硕士。